AR062

N/A

Report date: 2024/11/20 16:59:33

Base Information

Drug NameAR062
Drug Alias NameAR062
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionAnti-Ectonucleoside triphosphate diphosphohydrolase 1
TargetsEctonucleoside triphosphate diphosphohydrolase 1
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesY-biologics Inc
China Registration ClassN/A

Develop Information

Active CompaniesY-biologics Inc
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A